Candriam S.C.A. Seer, Inc. Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.03 - $8.58 $125,750 - $214,500	-25,000 Reduced 50.0%	25,000 $145,000
Q4 2021 Feb 10, 2022	BUY	$21.08 - $38.51 $400,519 - $731,690	19,000 Added 61.29%	50,000 $1.14 Million
Q3 2021 Nov 09, 2021	SELL	$27.67 - $45.04 $249,030 - $405,360	-9,000 Reduced 22.5%	31,000 $1.07 Million
Q2 2021 Jul 20, 2021	BUY	$28.75 - $56.92 $1.15 Million - $2.28 Million	40,000 New	40,000 $1.31 Million

39.7M

100

100

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $115M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.